home / stock / csii / csii quote
Last: | $20 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $20 |
High: | $0 |
Low: | $0 |
Volume: | 4,300 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$20 | $0 | $20 | $0 | $0 | 4,300 | 05-11-2023 |
$20 | $19.99 | $20 | $20 | $19.98 | 398,334 | 04-27-2023 |
$19.97 | $19.98 | $19.97 | $19.99 | $19.97 | 332,226 | 04-26-2023 |
$19.99 | $19.97 | $19.99 | $19.99 | $19.965 | 324,873 | 04-25-2023 |
$19.98 | $19.97 | $19.98 | $19.99 | $19.96 | 180,021 | 04-24-2023 |
$19.98 | $19.96 | $19.98 | $19.98 | $19.96 | 232,415 | 04-21-2023 |
$19.98 | $19.97 | $19.98 | $19.98 | $19.96 | 1,136,244 | 04-20-2023 |
$19.97 | $19.96 | $19.97 | $19.97 | $19.96 | 447,696 | 04-19-2023 |
$19.96 | $19.97 | $19.96 | $19.97 | $19.95 | 867,691 | 04-18-2023 |
$19.97 | $19.97 | $19.97 | $19.97 | $19.96 | 451,994 | 04-17-2023 |
$19.97 | $19.96 | $19.97 | $19.98 | $19.96 | 696,668 | 04-14-2023 |
$19.96 | $19.92 | $19.96 | $19.97 | $19.92 | 2,220,499 | 04-13-2023 |
$19.88 | $19.88 | $19.88 | $19.92 | $19.88 | 306,512 | 04-12-2023 |
$19.87 | $19.89 | $19.87 | $19.89 | $19.87 | 855,580 | 04-11-2023 |
$19.87 | $19.88 | $19.87 | $19.89 | $19.87 | 583,424 | 04-10-2023 |
$19.88 | $19.89 | $19.88 | $19.9 | $19.88 | 428,156 | 04-07-2023 |
$19.88 | $19.89 | $19.88 | $19.9 | $19.88 | 428,156 | 04-06-2023 |
$19.89 | $19.9 | $19.89 | $19.9 | $19.88 | 616,818 | 04-05-2023 |
$19.88 | $19.89 | $19.88 | $19.92 | $19.87 | 695,481 | 04-04-2023 |
$19.87 | $19.88 | $19.87 | $19.88 | $19.85 | 413,308 | 04-03-2023 |
News, Short Squeeze, Breakout and More Instantly...
Cardiovascular Systems Inc. Company Name:
CSII Stock Symbol:
NASDAQ Market:
Cardiovascular Systems Inc. Website:
Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...
Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...